A detailed history of Strategic Wealth Partners, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 12,338 shares of AMGN stock, worth $3.24 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
12,338
Previous 12,258 0.65%
Holding current value
$3.24 Million
Previous $3.83 Million 3.79%
% of portfolio
0.42%
Previous 0.41%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $24,750 - $26,990
80 Added 0.65%
12,338 $3.98 Million
Q2 2024

Oct 08, 2024

BUY
$262.75 - $319.31 $36,522 - $44,384
139 Added 1.15%
12,258 $3.83 Million
Q1 2024

May 20, 2024

BUY
$268.87 - $324.56 $3,764 - $4,543
14 Added 0.12%
12,119 $3.45 Million
Q4 2023

May 20, 2024

SELL
$255.7 - $288.46 $66,737 - $75,288
-261 Reduced 2.11%
12,105 $3.49 Million
Q3 2023

May 20, 2024

BUY
$218.65 - $271.46 $36,951 - $45,876
169 Added 1.39%
12,366 $3.32 Million
Q2 2023

May 20, 2024

BUY
$214.27 - $253.37 $5,999 - $7,094
28 Added 0.23%
12,197 $2.71 Million
Q1 2023

Apr 24, 2023

SELL
$225.79 - $275.2 $952,833 - $1.16 Million
-4,220 Reduced 25.75%
12,169 $2.94 Million
Q4 2022

Apr 24, 2023

SELL
$229.03 - $291.01 $1,603 - $2,037
-7 Reduced 0.04%
16,389 $4.3 Million
Q3 2022

Apr 24, 2023

BUY
$224.46 - $253.15 $3.31 Million - $3.74 Million
14,766 Added 905.89%
16,396 $3.7 Million
Q2 2022

Aug 22, 2022

BUY
$230.71 - $256.74 $41,989 - $46,726
182 Added 12.57%
1,630 $397,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $147,370 - $168,651
-741 Reduced 33.85%
1,448 $325,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $177,882 - $208,410
-838 Reduced 27.68%
2,189 $465,000
Q2 2021

Aug 25, 2021

BUY
$233.58 - $259.14 $407,597 - $452,199
1,745 Added 136.12%
3,027 $737,000
Q4 2020

Feb 18, 2021

SELL
$216.38 - $257.67 $45,223 - $53,853
-209 Reduced 14.02%
1,282 $295,000
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $77,903 - $86,635
-332 Reduced 18.21%
1,491 $379,000
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $239,943 - $294,443
-1,213 Reduced 39.95%
1,823 $430,000
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $553,280 - $733,801
3,036 New
3,036 $732,000
Q4 2019

Jan 30, 2020

SELL
$189.21 - $243.2 $741,513 - $953,100
-3,919 Closed
0 $0
Q3 2019

Oct 28, 2019

SELL
$174.11 - $208.62 $828,589 - $992,822
-4,759 Reduced 54.84%
3,919 $117 Million
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $185,703 - $217,686
-1,114 Reduced 11.38%
8,678 $1.6 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $171,826 - $193,686
950 Added 10.74%
9,792 $1.88 Million
Q4 2018

Jan 24, 2019

SELL
$178.4 - $208.25 $67,613 - $78,926
-379 Reduced 4.11%
8,842 $1.72 Million
Q3 2018

Dec 06, 2018

BUY
$185.29 - $208.89 $73,374 - $82,720
396 Added 4.49%
9,221 $1.91 Million
Q2 2018

Sep 04, 2018

SELL
$166.05 - $186.51 $636,635 - $715,079
-3,834 Reduced 30.29%
8,825 $1.63 Million
Q1 2018

Jul 13, 2018

BUY
$169.43 - $198.0 $2.14 Million - $2.51 Million
12,659 New
12,659 $2.16 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Strategic Wealth Partners, Ltd. Portfolio

Follow Strategic Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.